Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Dupixent® for Chronic Rhinosinusitis with Nasal Polyposis

americanpharmaceuticalreviewJune 27, 2019

Tag: FDA , Dupixent® , Chronic Rhinosinusitis

PharmaSources Customer Service